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rostaglandin and Echocardiography
hat’s what started this whole journey. Before the end of the 1970s, most
neonates with critical congenital heart disease (CHD) did not survive if their
pulmonary or systemic blood flow was dependent on a patent ductus arte-
iosus. Even in the rare neonate who was lucky enough to have spontaneous patency
f the ductus, making a complete diagnosis to plan cardiac surgery required
atheterization; 30 years ago cardiac catheterization was associated with significant
orbidity, especially in a fragile neonate. It’s no wonder surgical mortality was so
igh in those days. Even though the technical aspects of cardiac surgery could be
pplied to small babies, the status of the infant entering the operating room was
enuous, and the infant not infrequently had an incomplete diagnosis.
Enter bedside noninvasive diagnostic capabilities and the availability of medical
upport to stabilize the infant. Mechanical ventilation was being applied to smaller
nd smaller infants, hemodynamic monitoring was improving, and the new subspe-
ialty of cardiac intensive care allowed for increasingly stable babies to survive
alliative and reparative procedures. Improvements in surgical technique and car-
iopulmonary bypass followed soon thereafter. Intraoperative echocardiography
ncreased the likelihood of leaving the operating room with a better understanding
f the physiology of the neonate and status of the repair.
For those of us in the practice of pediatric cardiology, this was an exciting time
ndeed. Survival, even for infants with the most complex lesions, was now expected.
ardiologists and intensivists painted a very different prognosis for families than we
ad even 10 years earlier. However, with these successes came new realizations. As
e began to observe these outpatients in larger numbers, we recognized that there
as an unexpectedly high prevalence of psychosocial, neurologic, developmental,
nd psychiatric disabilities in the survivors as they entered and proceeded through
ormal education. Gross and fine motor delays, learning disabilities, inattention,
yperactivity, internalizing and externalizing behaviors, and speech and language
ifficulties have all been reported with disturbingly high frequency, approaching
0% to 50% in some subgroups.1 The neurodevelopmental burden of disease is, for
any children and their families, much more significant than the daily impact of
heir CHD.E1 (See E-References on line.) Many families of teenagers with complex
HD and significant learning or behavioral problems openly ask me why they were
ot informed of these potential problems when their children were born. It is of little
olace that I tell them that when their child was born in the late 1980s and early
990s, there were simply not enough school-age survivors to know the true impact
f CHD and its management on longer term quality of life. Fortunately, children and
heir parents began to participate in longitudinal clinical research efforts so that we
ight gain improved understanding of the types and frequency of neurodevelop-
ental dysfunction and begin to understand the mechanism(s) of injury.
vascular Surgery ● February 2008
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Lartnership and Equipoise
n this issue, the investigators at Children’s Hospital Boston
resent another in a series of important investigations aimed
t improving our understanding of the mechanisms of cen-
ral nervous system injury in the operating room and pro-
osing changes in management to improve the longer term
utlook for our current patients.2,3 At the outset, Newburger
cardiology), Jonas (cardiac surgery), Bellinger (psychol-
gy), Wypij (biostatistics), and their many colleagues un-
erstood the value in the multidisciplinary design of clinical
nvestigations. I was fortunate as a junior physician to be
entored by that group. Partnership extended from study
esign through implementation in the intensive care unit,
etting “buy-in” from colleagues in medicine, surgery, an-
sthesia, and nursing, and most importantly, the families of
ur patients. We believed then, as now, that clinical inves-
igation of long-term outcomes was a moral imperative and
ll needed to participate as partners in the challenge, from
any disciplines both inside and outside of pediatric cardi-
logy and surgery. Whereas getting many investigators (fre-
uently seasoned investigators with long research track
ecords) to agree on the important questions, the patient
opulation to study, the financial realities of clinical studies,
nd even the order of authors on manuscripts was “chal-
enging,” equipoise was perhaps the hardest of all hurdles to
vercome. In our field, it is natural to “know” (or be
xpected to know) the “correct” approach to a procedure,
he “right” diagnosis: the “truth.” How can a surgeon with
o much on the line be expected to “flip a coin” to decide
hat bypass strategy to use, what surgical technique to use?
ow could we convince parents of critically ill neonates to
ign a consent form allowing us to be—by design—random
n our decision making?E2 How could we convince our
olleagues who referred patients to us to allow their patients
o enter a clinical trial? These were difficult problems in
heory, but the leadership in the cardiovascular program
rovided by Dr Aldo Castañeda and Dr James Lock con-
inued to foster an approach that this was clearly the best
ay in which the field could move forward and improve
esults for the next generation. Multidisciplinary study
roups were encouraged and indeed became the model of
linical investigation of long-term outcomes for our
atients.
The knowledge gained from the randomized trials in
oston have included investigations of the use and du-
ation of deep hypothermic circulatory arrest,4,5,E6-E11 pH
anagement,6,E12 and, in the current issue, follow-up and
urther analysis on the effect of hematocrit management
uring cardiopulmonary bypass.2,3,E13 Much has been
earned from these trials that has affected our current ap-
roaches to cardiopulmonary bypass and perioperative man-
gement. In addition to the lessons learned from the impor-
ant trials in Boston, a subtle “culture change” has occurred i
The Journal of Thoracicn our field. New changes in technique are more frequently
ubjected to critical review and implemented as clinical
rials rather than immediately adopted as “better” or
proven.” Practice change by anecdote, seniority, or by
omparing new techniques to historical controls is no longer
 viable, acceptable strategy.E14 Additional randomized
linical trials of intraoperative and perioperative manage-
ent have recently been publishedE15,E16 and are currently
nderway, including multicenter trials supported by the
ediatric Heart Network (www.pediatricheartnetwork.org/
urrentstudies.asp, accessed 2007).
rospective and Evidence-based Studies
n addition to the randomized studies in Boston, a number of
ohorts are currently being evaluated prospectively with
rotocol-driven follow-up to learn more about the impact of
actors outside the operating room that affect long-term neu-
odevelopmental outcomes. Large cohorts of patients with
eterogeneous CHD are currently being prospectively fol-
owed up at The Children’s Hospital of Philadelphia7,E17-E20 as
ell as at Montreal Children’s Hospital8,E21-E28 and the Uni-
ersity Hospital in Aachen, Germany.9,E29-35 Additional pro-
pective and cross-sectional reports are increasingly prevalent
n the literature.E36-E42 All of the current evidence points to the
act that modifications of technique in the operating room,
lthough important, contribute but a small fraction to the
ariability of longer term outcomes in the decades that
ollow neonatal cardiac intervention. Instead, nonmodifiable
actors such as gestational age, birth weight, genetic syn-
romes and polymorphisms, maternal education, and socio-
conomic status have been consistently and significantly
mplicated as major contributors to long-term outcome.E43
herefore, prospective studies must continue to define the
mpact of modifiable risk factors: how we operate, when we
perate, and importantly, how we manage the patient in the
ntensive care unit. During a typical hospitalization for
eonatal heart surgery, only a small fraction of the total
ength of stay is spent in the operating room, where a
isproportionate (though very important) amount of clinical
nvestigation has taken place. Resources and clinical inves-
igations need also to study management patterns in the
ntensive care unit. Changes in management must be ac-
ompanied by investigation into their short- and long-term
mpact to establish an evidence base to design future pro-
pective follow-up studies and randomized treatment clini-
al trials. Just a few examples of practice patterns that have not
een adequately studied for their impact on longer term neu-
odevelopment include timing of surgery in critical lesions,
routine” delayed sternal closure,E44-E47 management of
yperglycemia,E48,E49 temperature control,E50-E52 nutrition,E53
nd the impact of mechanical ventilation/hyperventilationE54
n longer term outcomes. Some are likely to be important, and
t is time to study factors in the intensive care unit as
and Cardiovascular Surgery ● Volume 135, Number 2 241
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Ligorously as we have studied factors in the operating room.
e need to be more critical of our current strategies as
eing “right.” We should model our trials and clinical
nvestigations on the approach taken by the Boston group
or nearly 20 years, to have equipoise regarding our current
trategies, study them rigorously, in a multidisciplinary,
ulticenter, and importantly, long-term fashion. We may
nd that our practices and established techniques may be all
rong.
eferences
. Wernovsky G. Current insights regarding neurological and develop-
mental abnormalities in children and young adults with complex con-
genital cardiac disease. Cardiol Young. 2006;16(Suppl 1):92-104.
. Newburger JW, Jonas RA, Soul J, Kussman BD, Bellinger DC, Laussen
PC, et al. Randomized trial of hematocrit 25% versus 35% during
hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac
Cardiovasc Surg. 2008;135:347-54.
. Wypij D, Jonas RA, Bellinger DC, del Nido PJ, Mayer JE Jr, Bacha EA,
et al. The effect of hematocrit during hypothermic cardiopulmonary
42 The Journal of Thoracic and Cardiovascular Surgery ● Febrbypass in infant heart surgery: results from the combined Boston
hematocrit trials. J Thorac Cardiovasc Surg. 2008;135:355-60.
. Wypij D, Newburger JW, Rappaport LA, duPlessis AJ, Jonas RA,
Wernovsky G, et al. The effect of duration of deep hypothermic circu-
latory arrest in infant heart surgery on late neurodevelopment: the
Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003;126:
1397-403.
. Bellinger DC, Wypij D, duPlessis AJ, Rappaport LA, Jonas RA, Wer-
novsky G, et al. Neurodevelopmental status at eight years in children
with dextro-transposition of the great arteries: the Boston Circulatory
Arrest Trial. J Thorac Cardiovasc Surg. 2003;126:1385-96.
. du Plessis AJ, Jonas RA, Wypij D, Hickey PR, Riviello J, Wessel DL,
et al. Perioperative effects of alpha-stat versus pH-stat strategies for
deep hypothermic cardiopulmonary bypass in infants. J Thorac Car-
diovasc Surg. 1997;114:991-1000.
. Gaynor JW, Gerdes M, Zackai EH, Bernbaum J, Wernovsky G, Clancy
RR, et al. Apolipoprotein E genotype and neurodevelopmental sequelae of
infant cardiac surgery. J Thorac Cardiovasc Surg. 2003;126:1736-45.
. Majnemer A, Limperopoulos C, Shevell M, Rohlicek C, Rosenblatt B,
Tchervenkov C. Health and well-being of children with congenital
cardiac malformations, and their families, following open-heart surgery.
Cardiol Young. 2006;16:157-64.
. Hovels-Gurich HH, Konrad K, Skorzenski D, Herpertz-Dahlmann B,
Messmer BJ, Seghaye MC. Attentional dysfunction in children after cor-
rective cardiac surgery in infancy. Ann Thorac Surg. 2007;83:1425-30.
uary 2008
EWernovsky Editorials
ED
IT
O
RI
A
L-References
E1. Wray J, Maynard L. The needs of families of children with heart
disease. J Dev Behav Pediatr. 2006;27:11-7.
E2. Hoehn KS, Wernovsky G, Rychik J, Gaynor JW, Spray TL, Feudtner
C, et al. What factors are important to parents making decisions
about neonatal research? Arch Dis Child Fetal Neonatal Ed. 2005;
90:F267-9.
E3. McGrath E, Wypij D, Rappaport LA, Newburger JW, Bellinger DC.
Prediction of IQ and achievement at age 8 years from neurodevel-
opmental status at age 1 year in children with D-transposition of the
great arteries. Pediatrics. 2004;114:e572-6.
E4. Bartlett JM, Wypij D, Bellinger DC, Rappaport LA, Heffner LJ, Jonas
RA, et al. Effect of prenatal diagnosis on outcomes in D-transposition of
the great arteries. Pediatrics. 2004;113:e335-40.
E5. Newburger JW, Wypij D, Bellinger DC, du Plessis AJ, Kuban
KC, Rappaport LA, et al. Length of stay after infant heart surgery
is related to cognitive outcome at age 8 years. J Pediatr. 2003;
143:67-73.
E6. Dunbar-Masterson C, Wypij D, Bellinger DC, Rappaport LA, Baker
AL, Jonas RA, et al. General health status of children with D-
transposition of the great arteries after the arterial switch operation.
Circulation. 2001;104(12 Suppl 1):I138-42.
E7. Bellinger DC, Wypij D, Kuban KC, Rappaport LA, Hickey PR,
Wernovsky G, et al. Developmental and neurological status of chil-
dren at 4 years of age after heart surgery with hypothermic circula-
tory arrest or low-flow cardiopulmonary bypass. Circulation. 1999;
100:526-32.
E8. Rappaport LA, Wypij D, Bellinger DC, Helmers SL, Holmes GL,
Barnes PD, et al. Relation of seizures after cardiac surgery in early
infancy to neurodevelopmental outcome. Boston Circulatory Arrest
Study Group. Circulation. 1998;97:773-9.
E9. Bellinger DC, Rappaport LA, Wypij D, Wernovsky G, Newburger
JW. Patterns of developmental dysfunction after surgery during
infancy to correct transposition of the great arteries. J Dev Behav
Pediatr. 1997;18:75-83.
E10. Bellinger DC, Jonas RA, Rappaport LA, Wypij D, Wernovsky G,
Kuban KC, et al. Developmental and neurologic status of children
after heart surgery with hypothermic circulatory arrest or low-flow
cardiopulmonary bypass. N Engl J Med. 1995;332:549-55.
E11. Bellinger DC, Wernovsky G, Rappaport LA, Mayer JE Jr, Castaneda
AR, Farrell DM, et al. Cognitive development of children following
early repair of transposition of the great arteries using deep hypo-
thermic circulatory arrest. Pediatrics. 1991;87:701-7.
E12. Jonas RA, Bellinger DC, Rappaport LA, Wernovsky G, Hickey PR,
Farrell DM, et al. Relation of pH strategy and developmental out-
come after hypothermic circulatory arrest. J Thorac Cardiovasc
Surg. 1993;106:362-8.
E13. Jonas RA, Wypij D, Roth SJ, Bellinger DC, Visconti KJ, du Plessis
AJ, et al. The influence of hemodilution on outcome after hypother-
mic cardiopulmonary bypass: results of a randomized trial in infants.
J Thorac Cardiovasc Surg. 2003;126:1765-74.
E14. Tabbutt S, Dominguez TE, Ravishankar C, Marino BS, Gruber
PJ, Wernovsky G, et al. Outcomes after the stage I reconstruction
comparing the right ventricular to pulmonary artery conduit with
the modified Blalock Taussig shunt. Ann Thorac Surg. 2005;80:
1582-90.
E15. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang
AC, et al. Efficacy and safety of milrinone in preventing low cardiac
output syndrome in infants and children after corrective surgery for
congenital heart disease. Circulation. 2003;107:996-1002.
E16. Mackie AS, Booth KL, Newburger JW, Gauvreau K, Huang SA,
Laussen PC, et al. A randomized, double-blind, placebo-controlled
pilot trial of triiodothyronine in neonatal heart surgery. J Thorac
Cardiovasc Surg. 2005;130:810-6.
E17. Clancy RR, McGaurn SA, Goin JE, Hirtz DG, Norwood WI, Gaynor
JW, et al. Allopurinol neurocardiac protection trial in infants under-
going heart surgery using deep hypothermic circulatory arrest. Pe-
diatrics. 2001;108:61-70.
E18. Kaltman JR, Jarvik GP, Bernbaum J, Wernovsky G, Gerdes M,
Zackai E, et al. Neurodevelopmental outcome after early repair of a
The Journal of Thoracic aventricular septal defect with or without aortic arch obstruction.
J Thorac Cardiovasc Surg. 2006;131:792-8.
E19. Kirshbom PM, Flynn TB, Clancy RR, Ittenbach RF, Hartman DM,
Paridon SM, et al. Late neurodevelopmental outcome after repair of
total anomalous pulmonary venous connection. J Thorac Cardiovasc
Surg. 2005;129:1091-7.
E20. Schultz AH, Jarvik GP, Wernovsky G, Bernbaum J, Clancy RR,
D’Agostino JA, et al. Effect of congenital heart disease on neuro-
developmental outcomes within multiple-gestation births. J Thorac
Cardiovasc Surg. 2005;130:1511-6.
E21. Majnemer A, Limperopoulos C, Shevell M, Rosenblatt B, Rohlicek
C, Tchervenkov C. Long-term neuromotor outcome at school entry
of infants with congenital heart defects requiring open-heart surgery.
J Pediatr. 2006;148:72-7.
E22. Limperopoulos C, Majnemer A, Rosenblatt B, Shevell MI, Rohlicek
C, Tchervenkov C. Agreement between the neonatal neurological
examination and a standardized assessment of neurobehavioural
performance in a group of high-risk newborns. Pediatr Rehabil.
1997;1:9-14.
E23. Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek
C, Tchervenkov C. Neurologic status of newborns with congenital
heart defects before open heart surgery. Pediatrics. 1999;103:402-8.
E24. Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek
C, Tchervenkov C. Neurodevelopmental status of newborns and
infants with congenital heart defects before and after open heart
surgery. J Pediatr. 2000;137:638-45.
E25. Limperopoulos C, Majnemer A, Rosenblatt B, Shevell MI, Rohlicek
C, Tchervenkov C, et al. Association between electroencephalo-
graphic findings and neurologic status in infants with congenital
heart defects. J Child Neurol. 2001;16:471-6.
E26. Limperopoulos C, Majnemer A, Shevell MI, Rosenblatt B, Rohlicek
C, Tchervenkov C, et al. Functional limitations in young children
with congenital heart defects after cardiac surgery. Pediatrics. 2001;
108:1325-31.
E27. Limperopoulos C, Majnemer A, Shevell MI, Rohlicek C, Rosenblatt
B, Tchervenkov C, et al. Predictors of developmental disabilities
after open heart surgery in young children with congenital heart
defects. J Pediatr. 2002;141:51-8.
E28. Majnemer A, Limperopoulos C. Developmental progress of children
with congenital heart defects requiring open heart surgery. Semin
Pediatr Neurol. 1999;6:12-9.
E29. Hovels-Gurich HH, Konrad K, Skorzenski D, Nacken C, Minkenberg
R, Messmer BJ, et al. Long-term neurodevelopmental outcome and
exercise capacity after corrective surgery for tetralogy of Fallot or
ventricular septal defect in infancy. Ann Thorac Surg. 2006;81:958-66.
E30. Hovels-Gurich HH, Seghaye MC, Ma Q, Miskova M, Minkenberg
R, Messmer BJ, et al. Long-term results of cardiac and general health
status in children after neonatal arterial switch operation. Ann Thorac
Surg. 2003;75:935-43.
E31. Hovels-Gurich HH, Konrad K, Wiesner M, Minkenberg R, Herpertz-
Dahlmann B, Messmer BJ, et al. Long term behavioural outcome
after neonatal arterial switch operation for transposition of the great
arteries. Arch Dis Child. 2002;87:506-10.
E32. Hovels-Gurich HH, Seghaye MC, Schnitker R, Wiesner M, Huber
W, Minkenberg R, et al. Long-term neurodevelopmental outcomes in
school-aged children after neonatal arterial switch operation. J Tho-
rac Cardiovasc Surg. 2002;124:448-58.
E33. Hovels-Gurich HH, Seghaye MC, Sigler M, Kotlarek F, Bartl A,
Neuser J, et al. Neurodevelopmental outcome related to cerebral risk
factors in children after neonatal arterial switch operation. Ann
Thorac Surg. 2001;71:881-8.
E34. Hovels-Gurich HH, Seghaye MC, Dabritz S, Messmer BJ, von
Bernuth G. Cardiological and general health status in preschool- and
school-age children after neonatal arterial switch operation. Eur
J Cardiothorac Surg. 1997;12:593-601.
E35. Hovels-Gurich HH, Seghaye MC, Dabritz S, Messmer BJ, von
Bernuth G. Cognitive and motor development in preschool and
school-aged children after neonatal arterial switch operation. J Tho-
rac Cardiovasc Surg. 1997;114:578-85.
nd Cardiovascular Surgery ● Volume 135, Number 2 242.e1
Editorials Wernovsky
2
ED
ITO
RIA
LE36. Forbess JM, Visconti KJ, Bellinger DC, Jonas RA. Neurodevelop-
mental outcomes in children after the Fontan operation. Circulation.
2001;104(12 Suppl 1):I127-32.
E37. Forbess JM, Visconti KJ, Hancock-Friesen C, Howe RC, Bellinger
DC, Jonas RA. Neurodevelopmental outcome after congenital heart
surgery: results from an institutional registry. Circulation. 2002;
106(12 Suppl 1):I95-102.
E38. Forbess JM, Visconti KJ, Bellinger DC, Howe RJ, Jonas RA. Neu-
rodevelopmental outcomes after biventricular repair of congenital
heart defects. J Thorac Cardiovasc Surg. 2002;123:631-9.
E39. Wernovsky G, Stiles KM, Gauvreau K, Gentles TL, duPlessis AJ,
Bellinger DC, et al. Cognitive development after the Fontan opera-
tion. Circulation. 2000;102:883-9.
E40. Cheung PY, Chui N, Joffe AR, Rebeyka IM, Robertson CMT.
Postoperative lactate concentrations predict the outcome of infants
aged 6 weeks or less after intracardiac surgery: a cohort follow-up to
18 months. J Thorac Cardiovasc Surg. 2005;130:837-43.
E41. Dittrich H, Buhrer C, Grimmer I, Dittrich S, Abdul-Khaliq H, Lange
PE. Neurodevelopment at 1 year of age in infants with congenital
heart disease. Heart. 2003;89:436-41.
E42. Kern JH, Hinton VJ, Nereo NE, Hayes CJ, Gersony WM. Early
developmental outcome after the Norwood procedure for hypoplastic
left heart syndrome. Pediatrics. 1998;102:1148-52.
E43. Gaynor JW, Wernovsky G, Jarvik GP, Bernbaum J, Gerdes M, Zackai
E, et al. Patient characteristics are important determinants of neurode-
velopmental outcome at one year of age after neonatal and infant cardiac
surgery. J Thorac Cardiovasc Surg. 2007;133:1344-53.
E44. Owens WA, Vitale N, Hasan A, Hamilton JRL. A policy of elective
delayed sternal closure does not improve the outcome after arterial
switch. Ann Thorac Surg. 2001;71:1553-5.
E45. Riphagen S, McDougall M, Tibby SM, Alphonso N, Anderson D,
Austin C, et al. “Early” delayed sternal closure following pediatric
cardiac surgery. Ann Thorac Surg. 2005;80:678-85.
42.e2 The Journal of Thoracic and Cardiovascular Surgery ● FeE46. Samir K, Riberi A, Ghez O, Ali M, Metras D, Kreitmann B.
Delayed sternal closure: a life-saving measure in neonatal open
heart surgery; could it be predictable? Eur J Cardiothorac Surg.
2002;21:787-93.
E47. Tabbutt S, Duncan BW, McLaughlin D, Wessel DL, Jonas RA,
Laussen PC. Delayed sternal closure after cardiac operations in a
pediatric population. J Thorac Cardiovasc Surg. 1997;113:886-93.
E48. de Ferranti S, Gauvreau K, Hickey PR, Jonas RA, Wypij D, du
Plessis A. Intraoperative hyperglycemia during infant cardiac sur-
gery is not associated with adverse neurodevelopmental outcomes at
1, 4, and 8 years. Anesthesiology. 2004;100:1345-52.
E49. Yates AR, Dyke PC, Taeed R, Hoffman TM, Hayes J, Feltes TF, et
al. Hyperglycemia is a marker for poor outcome in the postoperative
pediatric cardiac patient. Pediatr Crit Care Med. 2006;7:351-5.
E50. Cottrell SM, Morris KP, Davies P, Bellinger DC, Jonas RA, New-
burger JW. Early postoperative body temperature and developmental
outcome after open heart surgery in infants. Ann Thorac Surg.
2004;77:66-71.
E51. Sakamoto T, Zurakowski D, Duebener LF, Lidov HG, Holmes GL,
Hurley RJ, et al. Interaction of temperature with hematocrit level and
pH determines safe duration of hypothermic circulatory arrest.
J Thorac Cardiovasc Surg. 2004;128:220-32.
E52. Tabbutt S, Ittenbach RF, Nicolson SC, Burnham N, Hittle S, Spray
TL, et al. Intracardiac temperature monitoring in infants after cardiac
surgery. J Thorac Cardiovasc Surg. 2006;131:614-20.
E53. Kelleher DK, Laussen P, Teixeira-Pinto A, Duggan C. Growth and
correlates of nutritional status among infants with hypoplastic left
heart syndrome (HLHS) after stage 1 Norwood procedure. Nutrition.
2006;223:237-44.
E54. Bassan H, Gauvreau K, Newburger JW, Tsuji M, Limperopoulos C,
Soul JS, et al. Identification of pressure passive cerebral perfusion
and its mediators after infant cardiac surgery. Pediatr Res. 2005;57:
35-41.
bruary 2008
